Statins Are Associated With Reduced Mortality in Multiple Myeloma

PURPOSE: The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) have activity in one of the pathways influenced by nitrogen-containing bisphosphonates, which are associated with improved survival in multiple myeloma (MM). To understand the benefit of statins in MM, we evaluated the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Sanfilippo, Kristen Marie, Keller, Jesse, Gage, Brian F., Luo, Suhong, Wang, Tzu-Fei, Moskowitz, Gerald, Gumbel, Jason, Blue, Brandon, O’Brian, Katiuscia, Carson, Kenneth R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2016
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477827/
https://ncbi.nlm.nih.gov/pubmed/27646948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.68.3482
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak